<DOC>
	<DOCNO>NCT02740582</DOCNO>
	<brief_summary>The purpose study determine effect tolcapone decision make alcohol intake use laboratory bar ( on-site alcohol self-administration ) alcohol drinker .</brief_summary>
	<brief_title>Effects Tolcapone Decision Making Alcohol Intake Alcohol Users</brief_title>
	<detailed_description>The study 7-session , double blind , placebo-controlled crossover study effect tolcapone , COMT inhibitor , decision make alcohol intake use laboratory bar moderate heavy social alcohol drinker . Subjects moderate heavy social user alcohol , define least 10 standard drink per week woman least 14 standard drink per week men . There one screening session follow six additional visit include 2 laboratory bar session . On study drug administration day , subject come clinic medication dispensation visit instruction take study drug remainder study . Study drug bottle equip MEMS cap ensure compliance . After 5 day drug administration , subject return clinic laboratory bar . This session consist administration standardize laboratory bar paradigm series computerize write decision-making task . Subjects cross complete series study visit alternate study drug .</detailed_description>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Alcohol Drinking</mesh_term>
	<mesh_term>Impulsive Behavior</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Tolcapone</mesh_term>
	<criteria>Healthy volunteer 2140 year age If female , 10 alcoholic drink must consume weekly . If male , 14 alcoholic drink must consume weekly . Meets DSMV criterion Alcohol Use Disorder ( AUD ) . If female , must nonlactating , pregnant , use reliable contraception method ( i.e . abstinence , intrauterine device [ IUD ] , hormonal birth control , barrier method ) . Ability read speak English . High school graduate . Able willing provide inform consent . Able understand follow instruction investigator , include delay discounting task . Residing within 5 mile study site . Positive urine drug screen ( except marijuana ) . Using cocaine , stimulant ( nicotine caffeine ) , amphetamine , hallucinogen , ecstasy , opiates , sedative , pain pill , sleep pill . psychoactive drug within 2 week start study ( except marijuana ) . Marijuana use 3 times/week . Current enrollment alcohol , drug treatment program current legal problem relate alcohol , drug use . Currently try quit alcohol use . History major alcohol relate complication within precede 2 year ( liver failure/cirrhosis , pancreatitis , esophageal varix , etc. ) . Two SGPT/ALT SGOT/AST value great upper limit normal . Unable pass Standard Field Sobriety Test sober state ( BAC = 0.00 ) . BAC level &gt; 0.05 % begin screen visit ( within margin error detection ) . Regular use drug tolcapone contraindication list OR within 2 week drug administration . Severe low blood ( &lt; 90/50 ) pressure uncontrolled high blood pressure ( &gt; 160/100 ) . Allergy intolerance tolcapone . Subject receive investigational drug within 30 day screen visit . Subject consider unsuitable study opinion investigator clinician reason ( Axis II personality disorder make subject unable comply study instruction , per Clinician 's judgement . )</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>